The market opened in the green on January 28, 2020. The previous day witnessed the Sensex going down by 458.07 points to end at 41,155.12 and the Nifty was down by 129.25 points to close at 12,119. 

Committing mistake is a part of our lives. However, there are certain mistakes like ‘investing mistakes’ that might hurt a lot. So, in this article, we will learn about the ways to avoid investing mistakes.

The pharma major on Monday released a press note after the market hours, which mentioned about the approval of fundraising.

Cipla today informed the bourses that it has received an Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA), indicating the closure of the inspection at Invagen (US) manufacturing facility

Azithromycin tablets are used to treat different types of infections caused by bacteria, such as respiratory, skin, ear and eye infections. Alembic has a cumulative total of 115 ANDA approvals (103 final approvals and 12 tentative approvals) from USFDA.

January 9 gap area is likely to be an important support to watch out and on the upside, the level of the zone of 12,230-12,280 is likely to act as a resistance in the short-term. Stocks in news: Prakash Industries, Cholamandalam Investment and Finance Company, Maruti Suzuki India, Adani Gas, GHCL.

Indian markets are likely to extend their losses as the global weakness is sure to spill on the Indian shores as well. SGX Nifty, which is currently trading almost 20 points below its yesterday’s close, is already reflecting it.

Financial planning is a very essential thing one should consider doing. However, when financial advisers approach people, they come up with random reasons to avoid financial planning. Let’s find out what are the excuses people make in order to skip financial planning!

Lupin Limited, which is a popular pharmaceutical company, announced about their successful completion of inspection undertaken by UK Medicines and Healthcare Products Regulatory Agency (UKMHRA).